Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.47154
Abstract: This cohort study investigates the association of hormone receptor status and first-line endocrine therapy with survival among patients with hormone receptor–positive (HR+) and human epidermal growth factor receptor 2–positive (ERBB2+ metastatic breast cancer. read more here.
Keywords: erbb2 metastatic; survival; breast cancer; metastatic breast ... See more keywords
Estimated Prevalence of Metastatic Breast Cancer in England, 2016-2021
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.48069
Abstract: This case series study provides an estimate of total cases of metastatic breast cancer in England based on National Health Service data. read more here.
Keywords: estimated prevalence; breast cancer; cancer england; metastatic breast ... See more keywords
“Cluster Bomb” Based Bismuth Nano‐in‐Micro Spheres Formed Dry Powder Inhalation for Thermo‐Radio Sensitization Effects of Lung Metastatic Breast Cancer
Sign Up to like & getrecommendations! Published in 2023 at "Advanced Healthcare Materials"
DOI: 10.1002/adhm.202202622
Abstract: Lung metastatic breast cancer (LMBC) is mainly diagnosed through CT imaging and radiotherapy could be the most common method in the clinic to inhibit tumor proliferation. While the sensitivity of radiotherapy is always limited due… read more here.
Keywords: radiotherapy; breast cancer; metastatic breast; nano micro ... See more keywords
Metastatic breast cancer patients with lung or liver metastases should be distinguished before being treated with fulvestrant
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.2453
Abstract: Endocrine therapy is the preferred treatment for patients with hormone receptor ‐positive metastatic breast cancer (MBC). While visceral metastasis is a negative prognostic factor, few studies have distinguished between the prognoses of patients with metastases… read more here.
Keywords: patients lung; breast cancer; metastatic breast; cancer ... See more keywords
Health care‐related time costs in patients with metastatic breast cancer
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3461
Abstract: Burdens related to time spent receiving cancer care may be substantial for patients with incurable, life‐limiting cancers such as metastatic breast cancer (MBC). Estimates of time spent on health care are needed to inform treatment‐related… read more here.
Keywords: related time; time; breast cancer; metastatic breast ... See more keywords
Statin use in patients with hormone receptor‐positive metastatic breast cancer treated with everolimus and exemestane
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5369
Abstract: We analyzed the effect of statins in patients with hormone receptor‐positive (HR+) metastatic breast cancer treated with everolimus + exemestane (EverX). read more here.
Keywords: receptor positive; hormone receptor; positive metastatic; metastatic breast ... See more keywords
Fine needle aspiration of pancreatic lesions focusing on secondary tumors with emphasis of metastatic breast cancer: A clinicopathological study with follow‐up
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5374
Abstract: The data on metastatic tumors to the pancreas diagnosed by fine needle aspiration (FNA) biopsy is limited. We report our experience of FNA of primary and secondary pancreatic tumors emphasizing metastatic breast cancer in the… read more here.
Keywords: fine needle; breast cancer; needle aspiration; metastatic breast ... See more keywords
Multidimensional financial hardship among uninsured and insured young adult patients with metastatic breast cancer.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer medicine"
DOI: 10.1002/cam4.5885
Abstract: Little is known about the heterogeneous nature of financial hardship in younger patients with metastatic disease and the extent to which insurance protects against it. We examine the association between insurance status and multidimensional indicators… read more here.
Keywords: financial hardship; breast cancer; metastatic breast; patients metastatic ... See more keywords
Pegylated liposomal doxorubicin (PLD) in daily practice-A single center experience of treatment with PLD in patients with comorbidities and older patients with metastatic breast cancer.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer medicine"
DOI: 10.1002/cam4.6041
Abstract: PURPOSE Real-world data about pegylated liposomal doxorubicin (PLD) in patients with metastatic breast cancer (MBC) are limited. We have aimed to highlight the role of PLD in daily practice focusing on older patients and patients… read more here.
Keywords: older patients; breast cancer; metastatic breast; pld ... See more keywords
TRPS1 outperforms GATA3 in pleural effusions with metastatic breast carcinoma versus mesothelioma.
Sign Up to like & getrecommendations! Published in 2023 at "Diagnostic cytopathology"
DOI: 10.1002/dc.25148
Abstract: INTRODUCTION In evaluating malignant pleural fluid cytology, metastatic adenocarcinomas and mesotheliomas are often differential diagnoses. GATA binding protein 3 (GATA3) has historically been used to confirm metastatic breast carcinomas; however, GATA3 has low specificity if… read more here.
Keywords: breast; breast carcinoma; mesothelioma; metastatic breast ... See more keywords
Pseudocirrhosis and liver failure in patients with metastatic breast cancer after treatment with palbociclib
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology"
DOI: 10.1002/hep.28720
Abstract: Palbociclib is an oral, small-molecule, specific, and reversible inhibitor of cyclin-dependent kinases 4 and 6, recently approved for the treatment of hormone receptor–positive, human epidermal growth factor receptor 2–negative, metastatic breast cancer. Registration trials witnessed… read more here.
Keywords: treatment palbociclib; metastatic breast; treatment; breast cancer ... See more keywords